Lymphoma is one of the most common neoplasms in cats and can present in several different forms. Among them, mediastinal lymphoma is particularly notable because it mainly affects young cats and is frequently associated with feline leukemia virus (FeLV) infection.
Recently, we managed a particularly interesting clinical case: Kira, a young female cat, Scottish Fold, only 1 year and 3 months old, FeLV positive confirmed by PCR, that developed pleural effusion secondary to mediastinal lymphoma.
What Is Mediastinal Lymphoma in Cats?
The mediastinum is the area located between the lungs inside the thoracic cavity. In mediastinal lymphoma, neoplastic lymphoid cells proliferate within this region, often involving the thymus or mediastinal lymph nodes. As the mass enlarges, it can compress the lungs and interfere with normal breathing.
What Are the Common Symptoms of Mediastinal Lymphoma in Cats?
Owners usually seek veterinary attention because of:
- Increased respiratory effort
- Tachypnea
- Lethargy
- Reduced appetite
- Exercise intolerance
- Abnormal breathing posture.
In many cases, fluid accumulation within the thoracic cavity (pleural effusion) is present, significantly worsening respiratory compromise.
Clinical Case: Mediastinal Lymphoma in a Young FeLV-Positive Cat
This young cat was initially evaluated at another veterinary center due to respiratory distress. Pleural effusion was identified and thoracocentesis was performed. Cytology of the pleural fluid revealed a predominance of lymphocytes, raising suspicion for a lymphoproliferative process.
She was subsequently referred to our oncology service for further investigation and case management. At presentation, thoracic radiographs revealed a significant recurrence of pleural effusion and presence of a cranial mediastinal mass.
A repeat thoracocentesis was performed to stabilize her respiratory status, and chemotherapy with a CHOP protocol was promptly initiated.
The CHOP Protocol for Feline Mediastinal Lymphoma
The CHOP protocol is one of the most commonly used chemotherapy protocols for feline lymphoma. It combines different antineoplastic agents over several weeks with the goal of inducing disease remission.
Although the word “chemotherapy” can be frightening for many owners, veterinary oncology differs significantly from human oncology. Our primary goal is always to preserve quality of life.
Most cats tolerate treatment remarkably well when appropriate monitoring and supportive care are provided.
A Very Encouraging Response to Treatment
In this case, the initial response to treatment was extremely encouraging.
By the second chemotherapy session, the mediastinal mass was no longer visible on thoracic radiographs, demonstrating an excellent response to the protocol.
So far, the patient has maintained a very good quality of life, with minimal adverse effects thanks to close monitoring and comprehensive supportive care throughout treatment.
We are currently halfway through the planned 19-week CHOP protocol, and her clinical progression continues to be very positive.
The Role of FeLV
The association between FeLV and mediastinal lymphoma is well established. Feline leukemia virus can predispose cats to the development of hematopoietic neoplasms, particularly in young individuals.
Not every FeLV-positive cat will develop lymphoma, but the risk is significantly higher compared with FeLV-negative cats.
Prognosis for Cats with Mediastinal Lymphoma
The prognosis for mediastinal lymphoma can vary considerably depending on several factors, including:
- FeLV status
- Initial response to chemotherapy
- Presence of pleural effusion
- Overall clinical condition.
Although a lymphoma diagnosis is always emotionally challenging for owners, many cats can achieve clinical remission and maintain an excellent quality of life for months or even longer with appropriate treatment.
A Message for Cat Owners
Breathing difficulty in cats should never be ignored. In many cases, early diagnosis and intervention can make a substantial difference in both patient stabilization and treatment response.
Veterinary oncology has evolved tremendously over recent years, allowing us to offer increasingly effective and well-tolerated treatments focused on maintaining both comfort and quality of life for our patients.
